ClinicalTrials.Veeva

Menu

Renal Anemia Refractory to Erythropoietin

A

Assiut University

Status

Unknown

Conditions

ESRD
Renal Anemia

Study type

Observational

Funder types

Other

Identifiers

NCT03480178
17100366

Details and patient eligibility

About

This study evaluates the renal anemia refractory to Epo . in hemodialysis patients. all of participants will receive Epo. and identify various factors contributing to etiology of renal anemia in Epo- resistant patients.

Full description

Chronic kidney disease (CKD) is considered a public health problem worldwide with high incidence and prevalence rates.Anemia is one of the most frequent early complication of CKD. The main cause is erythropoietin (EPO) deficiency due to impaired kidney function However, other causes should be considered when the severity of anemia is inconsistent with the decrease in renal function; when there is evidence of iron deficiency or matching decreases in hemoglobin, leukopenia and/or thrombocytopenia are also found

Enrollment

1 estimated patient

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients greater than or equal to 18 years old with CKD on hemodialysis

Exclusion criteria

    • Evidence of infections especial of vascular access .
    • malnutrition and manifestation of iron, B12, folate and protein deficiency .
    • any underling cause as;

    • Hematologic malignances -Hemolytic anemia -
    • Aplastic anemia (infection and/or bleeding with anemia)
    • Solid tumors
    • Bleeding (skin ,mucosal ,orificial)
    • Evidence of mineral bone disease (CKD-MBD)
    • Others

Trial contacts and locations

0

Loading...

Central trial contact

zaher alwi, master; Mohamed Sabah, prof.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems